REGENXBIO Inc. (RGNX) Total liabilities 2016–2025
REGENXBIO Inc. (RGNX) total liabilities at each fiscal year-end, per SEC filings.
$350.3MFY2025 · since FY2016: $11.0M → $350.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $350.3M | +69.8% |
| FY2024 | $206.3M | -21.3% |
| FY2023 | $262.2M | -17.3% |
| FY2022 | $317.1M | -9.3% |
| FY2021 | $349.6M | +5.8% |
| FY2020 | $330.4M | +592.5% |
| FY2019 | $47.7M | +36.4% |
| FY2018 | $35.0M | +123.5% |
| FY2017 | $15.6M | +42.3% |
| FY2016 | $11.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More RGNX financial trends
RGNX RevenueRGNX Net incomeRGNX Net marginRGNX Gross profitRGNX Gross marginRGNX Operating incomeRGNX Operating marginRGNX Operating cash flowRGNX Free cash flowRGNX Capital expendituresRGNX Return on equityRGNX Stock buybacksRGNX Dividends paidRGNX Total assetsRGNX Shareholders’ equityRGNX overview →